During the past decade, California Retina Consultants conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Retina Consultants" #1 sponsor was "California Retina Consultants" with 5 trials, followed by "Kodiak Sciences Inc" with 4 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Aerpio Therapeutics" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Retina Consultants" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "California Retina Consultants" with 1 trials as a collaborator, "Northwestern University" with 1 trials as a collaborator and "Ocular Therapeutix, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "California Retina Consultants" are "Geographic Atrophy" (6 trials), "Diabetic Macular Edema" (5 trials), "Macular Degeneration, Age-Related" (3 trials), "Central Retinal Vein Occlusion" (2 trials) and "Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "California Retina Consultants" in a lesser frequency.

Most popular intervention types in "California Retina Consultants" are "Drug" (17 trials), "Other" (5 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "KSI-301" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Galegenimab" (2 trials) and "Ranibizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "California Retina Consultants" are 20 trials for "All" genders.

Currently, there are NaN active trials in "California Retina Consultants". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in California Retina Consultants, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in California Retina Consultants, 7 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".